Revat Laboratories Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 1988.
1988 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Revat Laboratories Private Limited

Revat Laboratories Private Limited, a active private limited company, was established on 07 June 1988 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230TG1988PTC008741. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.50 Cr and a paid-up capital of ₹5.33 Cr.

Formerly known as Minopharm Laboratories Private Limited. It upholds a compliant status. Employing 5 professional, Its leadership includes Aruna Karusala (Director), Anil Kumar Karusala (Director), Vijitha Gorrepati (Director). Past directors included Rajini Kumari Gorantla, Anil Kumar Karusala, Vijitha Gorrepati. It holds ₹61.90 Cr open charges and ₹62.85 Cr settled loans. Its latest AGM occurred on 29 September 2024, with the balance sheet filed on 31 March 2024. It is based at 4Th Floor, Lavanya Arcade, Plot No. 39 Jayabheri Enclave, Gachibowli, Hyderabad, Telangana, 500032.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230TG1988PTC008741

  • Registration Number

    008741

  • Incorporation Date

    07 June 1988

  • Authorized Capital

    ₹5.50 Cr

  • Paid-Up Capital

    ₹5.33 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.50 Cr
  • Paid Up Capital ₹ 5.33 Cr
  • Company Age 37 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 61.90 Cr
  • Satisfied Charges ₹ 62.85 Cr
  • Revenue Growth **** 35.90%
  • Profit Growth **** 104.74%
  • Ebitda **** 44.62%
  • Net Worth 32.45%
  • Total Assets **** 34.14%
Company report

Revat Laboratories Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Revat Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Revat Laboratories Private Limited?
Current Directors
Name Designation Appointment Date Status
Aruna Karusala Director 07 Jun 1988 Current
Anil Kumar Karusala Director 15 Mar 1994 Current
Vijitha Gorrepati Director 28 Mar 2011 Current
Bhagyashri Dharmasa Zad Director 26 Aug 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 16 Jul 2019 Past
Pramod Abcsdd Managing Director 30 Nov 2023 Past
Pramod Abcsdd Additional Director 30 Sep 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Revat Laboratories.

Revat Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 35.9% increase. The company also saw a substantial improvement in profitability, with a 104.74% increase in profit. The company's net worth Soared by an impressive increase of 32.45%.

Revat Laboratories revenue growth over time
Revat Laboratories profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 35.90%
*******
*******
*******
*******
Revenue from Operations
*******
 35.84%
*******
*******
*******
*******
Total Assets
*******
 34.14%
*******
*******
*******
*******
Profit or Loss
*******
 104.74%
*******
*******
*******
*******
Net Worth
*******
 32.45%
*******
*******
*******
*******
EBITDA
*******
 44.62%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Revat Laboratories?

In 2022, Revat Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹619,030,000.00

Satisfied Charges

₹628,468,000.00

Charges Breakdown by Lending Institutions
  • City Union Bank Limited : 29.71 Cr
  • Others : 26.90 Cr
  • The Hongkong And Shanghai Banking Corporation Limited : 5.00 Cr
  • State Bank Of India : 0.20 Cr
  • Andhra Bank : 0.09 Cr
Latest Charge Details
Date Lender Amount Status
19 Feb 2022 The Hongkong And Shanghai Banking Corporation Limited ₹5.00 Cr Open
10 May 2019 City Union Bank Limited ₹29.71 Cr Open
12 Apr 2016 Others ₹26.90 Cr Open
16 May 1994 State Bank Of India ₹2.00 M Open
05 Jul 1989 Andhra Bank ₹0.90 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Revat Laboratories?

Revat Laboratories has a workforce of 5 employees as of Mar 21, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Revat Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Revat Laboratories's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Revat Laboratories
Recent Activity within the Organization
  • Director Appointment

    Progress on Bhagyashri Dharmasa Zad was appointed as a Director was appointed as a Director on 26 Aug 2025 & has been associated with this company since 9 months 4 days . was documented.

  • Charges

    A charge registered on 21 Oct 2021 via Charge ID 100510522 with City Union Bank Limited was fully satisfied on 16 Jun 2025. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 12 Jul 2021 via Charge ID 100470021 with City Union Bank Limited was fully satisfied on 16 Jun 2025. was documented.

  • Charges

    Progress on A charge registered on 18 May 2019 via Charge ID 100267708 with City Union Bank Limited was fully satisfied on 16 Jun 2025. was documented.

  • Annual General Meeting

    Revat Laboratories Private Limited last Annual general meeting of members was held on 29 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Charges

    The activity A charge registered on 30 Mar 2022 via Charge ID 100552025 with Sidbi was fully satisfied on 10 Sep 2024. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Revat Laboratories Private Limited?

The CIN of Revat Laboratories Private Limited is U24230TG1988PTC008741.

Where is Revat Laboratories Private Limited headquartered?

Revat Laboratories Private Limited is headquartered at 4Th Floor, Lavanya Arcade, Plot No. 39 Jayabheri Enclave, Gachibowli, Hyderabad, Telangana, 500032.

When was Revat Laboratories Private Limited incorporated?

Revat Laboratories Private Limited was incorporated on 07 June 1988.

Who are the current directors of Revat Laboratories Private Limited?

The current directors of Revat Laboratories Private Limited are

What is the primary industry of Revat Laboratories Private Limited?

The primary industry of Revat Laboratories Private Limited is Manufacturing.

Is Revat Laboratories Private Limited a listed company?

Revat Laboratories Private Limited is unlisted.

What is the capital structure of Revat Laboratories Private Limited?

The authorized capital of Revat Laboratories Private Limited is ₹5.50 Cr, and the paid-up capital is ₹5.33 Cr.

What is the compliance status of Revat Laboratories Private Limited?

The compliance status of Revat Laboratories Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available